Escherichia coli is the most common cause of community-acquired urinary tract infection (UTI) and a leading cause of nosocomial UTIs and sepsis. We have focused on a genetic island at argW in E.coli urosepsis strain CFT073 which contains the dsdCXA genes for D- serine utilization and ipuAB, homologs of fimBE, the type 1 fimbriae phase-switch recombinases. A CFT073 dsdA mutant lacking D-serine deaminase is 300-fold more competitive than wild type CFT073 in colonizing the bladder or kidney of experimentally infected mice. Compared to CFT073, 44 and 41 genes were respectively up- and down- regulated in the CFT073 dsdA mutant during murine UTI. Up-regulated genes encoded P and F1C fimbriae, hemolysin, OmpF, a dipeptide transporter DppA, and several genes with unknown functions. CFT073 as well as other uropathogenic E. coli show (+) chemotaxis toward D-serine, but not L-serine as is the case E. coli K-12. ipuA has fimB-like ON-to-OFF and OFF-to-ON fimS switching activity during murine UTI. A CFT073 dsdA::lacZ transcriptional fusion undergoes reversible phase-switching albeit by an unidentified mechanism affected by ipuA and ipuB mutations. ipuA and ipuB also control a fimS- independent reversible phase switch of a set of genes encoding secreted products that includes the hemolysin. Therefore, we generated strong support of our original hypotheses that D-serine represents an important signal for regulation of CFT073 virulence genes and growth in the urinary tract and that the dsdCXA-linked recombinases mediate phase-state regulation of important urovirulence and fitness factors besides the type 1 fimbriae. We will investigate the mechanism whereby elevated intracellular D-serine leads to up-regulation of urovirulence and fitness genes and characterize loci aside from fimS that are controlled by the recombinases. We will use the CFT073 dsdA mutant as a model of the DsdA OFF state to study the roles of P fimbriae and hemolysin in colonization of the murine bladder and kidney. The objective of our project is to identify and characterize virulence genes for E. coli involved in serious human diseases. This work will aid development of new vaccines and antimicrobials. To that end, we have recently acquired evidence that the D-serine deaminase can serve as a novel drug target for identification of new antimicrobials.

Public Health Relevance

Escherichia coli is the most common cause of community-acquired urinary tract infection (UTI) and a leading cause of nosocomial UTIs and sepsis. The objective of our project is to identify and characterize virulence genes for E. coli involved in serious human diseases. This work will aid development of new vaccines and antimicrobials. To that end, we have recently acquired evidence that the D-serine deaminase can serve as a novel drug target for identification of new antimicrobials.

Agency
National Institute of Health (NIH)
Institute
National Institute of Diabetes and Digestive and Kidney Diseases (NIDDK)
Type
Research Project (R01)
Project #
5R01DK063250-10
Application #
8448312
Study Section
Special Emphasis Panel (ZRG1-RUS-F (02))
Program Officer
Bavendam, Tamara G
Project Start
2009-06-01
Project End
2014-01-31
Budget Start
2013-04-01
Budget End
2014-01-31
Support Year
10
Fiscal Year
2013
Total Cost
$299,095
Indirect Cost
$93,384
Name
University of Wisconsin Madison
Department
Microbiology/Immun/Virology
Type
Schools of Medicine
DUNS #
161202122
City
Madison
State
WI
Country
United States
Zip Code
53715
Hryckowian, Andrew J; Battesti, Aurelia; Lemke, Justin J et al. (2014) IraL is an RssB anti-adaptor that stabilizes RpoS during logarithmic phase growth in Escherichia coli and Shigella. MBio 5:e01043-14
Baisa, Gary; Stabo, Nicholas J; Welch, Rodney A (2013) Characterization of Escherichia coli D-cycloserine transport and resistant mutants. J Bacteriol 195:1389-99
Hryckowian, Andrew J; Welch, Rodney A (2013) RpoS contributes to phagocyte oxidase-mediated stress resistance during urinary tract infection by Escherichia coli CFT073. MBio 4:e00023-13
Raterman, Erica L; Welch, Rodney A (2013) Chemoreceptors of Escherichia coli CFT073 play redundant roles in chemotaxis toward urine. PLoS One 8:e54133
Raterman, Erica L; Shapiro, Daniel D; Stevens, Daniel J et al. (2013) Genetic analysis of the role of yfiR in the ability of Escherichia coli CFT073 to control cellular cyclic dimeric GMP levels and to persist in the urinary tract. Infect Immun 81:3089-98
Battaglioli, E J; Baisa, G A; Weeks, A E et al. (2011) Isolation of generalized transducing bacteriophages for uropathogenic strains of Escherichia coli. Appl Environ Microbiol 77:6630-5
Anfora, Andrew T; Halladin, David K; Haugen, Brian J et al. (2008) Uropathogenic Escherichia coli CFT073 is adapted to acetatogenic growth but does not require acetate during murine urinary tract infection. Infect Immun 76:5760-7
Anfora, Andrew T; Haugen, Brian J; Roesch, Paula et al. (2007) Roles of serine accumulation and catabolism in the colonization of the murine urinary tract by Escherichia coli CFT073. Infect Immun 75:5298-304
Haugen, Brian J; Pellett, Shahaireen; Redford, Peter et al. (2007) In vivo gene expression analysis identifies genes required for enhanced colonization of the mouse urinary tract by uropathogenic Escherichia coli strain CFT073 dsdA. Infect Immun 75:278-89
Mansson, Lisa E; Kjall, Peter; Pellett, Shahaireen et al. (2007) Role of the lipopolysaccharide-CD14 complex for the activity of hemolysin from uropathogenic Escherichia coli. Infect Immun 75:997-1004

Showing the most recent 10 out of 16 publications